» Articles » PMID: 16036808

Cocaine Increases Human Immunodeficiency Virus Type 1 Neuroinvasion Through Remodeling Brain Microvascular Endothelial Cells

Overview
Journal J Neurovirol
Publisher Springer
Specialties Microbiology
Neurology
Date 2005 Jul 23
PMID 16036808
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine is a suspected cofactor in human immunodeficiency virus (HIV)-associated dementia but cocaine's effects are not clear. Herein the authors describe investigations of the mechanisms by which cocaine increases HIV-1 invasion through brain microvascular endothelial cells (BMVECs). Cocaine binds to a site on BMVECs, which is not a biogenic amine transporter, a binding site for estrogen, or a muscarinic receptor and for which benztropine and tamoxifen have the highest affinity. Cocaine treatment of BMVECs disrupts intercellular junctions and induces cell ruffling, which could account for their increased permeability and decreased electrical resistance. HIV-1 enters BMVECs by macropinocytosis and is transported to lysosomes and inactivated. In cocaine-treated BMVECs, the virus enters and persists in large cytoplasmic "lakes." Cocaine exposure of BMVECs up-regulates transcription of genes important in cytoskeleton organization, signal transduction, cell swelling, vesicular trafficking, and cell adhesion. The toxicity of cocaine for the blood-brain barrier may lead to increased virus neuroinvasion and neurovascular complications of cocaine abuse.

Citing Articles

MicroRNAs in HIV infection: dual regulators of viral replication and host immunity.

Mansour R, El-Sayyad G, Rizk N, Mageed S, Basiouny M, El-Sayed S Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40029387 DOI: 10.1007/s00210-025-03893-7.


Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse.

Annadurai N, Kanmogne G Cells. 2024; 13(17.

PMID: 39272987 PMC: 11393916. DOI: 10.3390/cells13171415.


Neurovascular effects of cocaine: relevance to addiction.

Clare K, Park K, Pan Y, Lejuez C, Volkow N, Du C Front Pharmacol. 2024; 15:1357422.

PMID: 38455961 PMC: 10917943. DOI: 10.3389/fphar.2024.1357422.


Substance abuse and neurodegenerative diseases: focus on ferroptosis.

Guo C, Chen L, Wang Y Arch Toxicol. 2023; 97(6):1519-1528.

PMID: 37100932 DOI: 10.1007/s00204-023-03505-4.


High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats.

Yang J, Betterton R, Williams E, Stanton J, Reddell E, Ogbonnaya C Pharmaceutics. 2022; 14(5).

PMID: 35631535 PMC: 9144323. DOI: 10.3390/pharmaceutics14050949.


References
1.
Bouwman F, Skolasky R, Hes D, Selnes O, Glass J, Royal W . Variable progression of HIV-associated dementia. Neurology. 1998; 50(6):1814-20. DOI: 10.1212/wnl.50.6.1814. View

2.
Davis L, Hjelle B, Miller V, PALMER D, Llewellyn A, Merlin T . Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992; 42(9):1736-9. DOI: 10.1212/wnl.42.9.1736. View

3.
RESNICK L, Berger J, Shapshak P, Tourtellotte W . Early penetration of the blood-brain-barrier by HIV. Neurology. 1988; 38(1):9-14. DOI: 10.1212/wnl.38.1.9. View

4.
Liu N, Lossinsky A, Popik W, Li X, Gujuluva C, Kriederman B . Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol. 2002; 76(13):6689-700. PMC: 136265. DOI: 10.1128/jvi.76.13.6689-6700.2002. View

5.
Williams K, Hickey W . Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci. 2002; 25:537-62. DOI: 10.1146/annurev.neuro.25.112701.142822. View